CE vs PBYI · rev $5.09B vs P/E 4.3, rev $56.5M
Celanese Corporation (CE) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
CE currently screens at market cap $5.92B. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the CE and PBYI stock pages for the full models.
Not investment advice.